NurExone Biologic Inc. (NRXBF)
OTCMKTS · Delayed Price · Currency is USD
0.4617
-0.0229 (-4.72%)
Feb 11, 2026, 9:30 AM EST
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of $42.07 million as of February 12, 2026. Its market cap has increased by 39.67% in one year.
Market Cap
42.07M
Enterprise Value
41.14M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.46
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 25.82M to 42.07M, an increase of 62.91%. That is a compound annual growth rate of 14.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 42.07M | -3.62% |
| Dec 31, 2025 | 43.65M | 42.89% |
| Dec 31, 2024 | 30.55M | 183.25% |
| Dec 28, 2023 | 10.78M | -11.85% |
| Dec 22, 2022 | 12.24M | -52.62% |
| Jun 23, 2022 | 25.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |
| Vicapsys Life Sciences | 48.56M |
| Arch Biopartners | 43.72M |
| Cell Source | 41.50M |
| ZIVO Bioscience | 40.77M |
| Harvard Apparatus Regenerative Technology | 31.65M |
| Oncotelic Therapeutics | 28.70M |